STEMPOINT CAPITAL LP - 30 Sep 2025 SCHEDULE 13G Report for Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share (XLO)

Filing Manager
STEMPOINT CAPITAL LP
Reporting Manager
StemPoint Capital LP
Security
Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol
XLO
Shares outstanding
55,555,556 shares
Disclosed Ownership
4,000,000 shares
Ownership
7.2%
Form type
SCHEDULE 13G
Filing time
14 Nov 2025, 10:00:24 UTC
Date of event
30 Sep 2025
Next filing
17 Feb 2026
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
StemPoint Capital LP 7.2% 4,000,000 0 4,000,000 /s/ Sean C. Tan Sean C. Tan, Authorized Signatory
StemPoint Capital Management GP LLC 7.2% 4,000,000 0 4,000,000 /s/ Sean C. Tan Sean C. Tan, Authorized Signatory
Michelle Ross 7.2% 4,000,000 0 4,000,000 /s/ Michelle Ross Michelle Ross